Edwards Lifesciences (EW) Tops Q1 EPS by 6c, Revenues Beat; Offers FY21 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Edwards Lifesciences (EW) Tops Q1 EPS by 6c, Revenues Beat; Offers FY21 EPS Outlook
April 21, 2021 9:22 AM EDT
Piper Sandler analyst Adam Maeder raised the price target on Edwards Lifesciences (NYSE: EW) to $105.00 (from $97.00) while maintaining a Overweight rating.
...
More
April 21, 2021 8:26 AM EDT
Canaccord Genuity analyst Jason Mills raised the price target on Edwards Lifesciences (NYSE: EW) to $103.00 (from $94.00) while maintaining a Buy rating.
The analyst commented, "EW Q1/21 revenue of $1,217M (+7.8% GAAP Y/Y; +5.0% adjusted CC),beat our estimate of $1,176M and consensus of $1,162M. There was positive Y/Y growth from... More
April 21, 2021 8:16 AM EDT
Stifel analyst Rick Wise raised the price target on Edwards Lifesciences (NYSE: EW) to $103.00 (from $100.00) while maintaining a Buy rating.
The analyst commented, "Overall, Edwards better-than-expected 1Q21 results marked a solid start to 2021, and post-release recovery trend/guidance commentary left us feeling... More
April 21, 2021 8:09 AM EDT
Jefferies analyst Raj Denhoy raised the price target on Edwards Lifesciences (NYSE: EW) to $110.00 (from $105.00) while maintaining a Buy rating.
The analyst commented, "EW posted $60mn/$0.07 beat with US TAVR flat offset by a rebound OUS to low DDs(HSD in... More
